118 related articles for article (PubMed ID: 33979734)
1. Design, synthesis and anti-influenza virus activity of furan-substituted spirothiazolidinones.
Apaydın ÇB; Tansuyu M; Cesur Z; Naesens L; Göktaş F
Bioorg Chem; 2021 Jul; 112():104958. PubMed ID: 33979734
[TBL] [Abstract][Full Text] [Related]
2. Novel N-(1-thia-4-azaspiro[4.5]decan-4-yl)carboxamide derivatives as potent and selective influenza virus fusion inhibitors.
Göktaş F; Özbil M; Cesur N; Vanderlinden E; Naesens L; Cesur Z
Arch Pharm (Weinheim); 2019 Nov; 352(11):e1900028. PubMed ID: 31531897
[TBL] [Abstract][Full Text] [Related]
3. Microwave assisted synthesis and anti-influenza virus activity of 1-adamantyl substituted N-(1-thia-4-azaspiro[4.5]decan-4-yl)carboxamide derivatives.
Göktaş F; Vanderlinden E; Naesens L; Cesur N; Cesur Z
Bioorg Med Chem; 2012 Dec; 20(24):7155-9. PubMed ID: 23117173
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and anti-coronavirus activity of a series of 1-thia-4-azaspiro[4.5]decan-3-one derivatives.
Apaydın ÇB; Cesur N; Stevaert A; Naesens L; Cesur Z
Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800330. PubMed ID: 31073993
[TBL] [Abstract][Full Text] [Related]
5. Superior inhibition of influenza virus hemagglutinin-mediated fusion by indole-substituted spirothiazolidinones.
Cihan-Üstündağ G; Zopun M; Vanderlinden E; Ozkirimli E; Persoons L; Çapan G; Naesens L
Bioorg Med Chem; 2020 Jan; 28(1):115130. PubMed ID: 31753804
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, biological evaluation and molecular modeling of novel azaspiro dihydrotriazines as influenza virus inhibitors targeting the host factor dihydrofolate reductase (DHFR).
Francesconi V; Giovannini L; Santucci M; Cichero E; Costi MP; Naesens L; Giordanetto F; Tonelli M
Eur J Med Chem; 2018 Jul; 155():229-243. PubMed ID: 29886325
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of new N-(3-oxo-1-thia-4-azaspiro[4.5]decan-4-yl)pyridine-3-carboxamide derivatives and evaluation of their anti-influenza virus and antitubercular activities.
Cihan-Üstündağ G; Acar Ç; Naesens L; Erköse-Genç G; Şatana D
Arch Pharm (Weinheim); 2022 Oct; 355(10):e2200224. PubMed ID: 35849096
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, docking, and antiviral evaluation of some novel pyrimidinone-based α-aminophosphonates as potent H1N1 and HCoV-229E inhibitors.
Hekal HA; Hammad OM; El-Brollosy NR; Salem MM; Allayeh AK
Bioorg Chem; 2024 Jun; 147():107353. PubMed ID: 38615475
[TBL] [Abstract][Full Text] [Related]
9. One-pot synthesis, characterization and antiviral properties of new benzenesulfonamide-based spirothiazolidinones.
Apaydın ÇB; Naesens L; Cihan-Üstündağ G
Mol Divers; 2024 Jun; ():. PubMed ID: 38935302
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and bioassay of 4-thiazolinone derivatives as influenza neuraminidase inhibitors.
Xiao M; Xu L; Lin D; Lian W; Cui M; Zhang M; Yan X; Li S; Zhao J; Ye J; Liu A; Hu A
Eur J Med Chem; 2021 Mar; 213():113161. PubMed ID: 33540229
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of novel 1, 3, 4-oxadiazole derivatives as potent neuraminidase inhibitors.
Yu W; Ping Cheng L; Pang W; Ling Guo L
Bioorg Med Chem; 2022 Mar; 57():116647. PubMed ID: 35121400
[TBL] [Abstract][Full Text] [Related]
12. Novel N-Substituted oseltamivir derivatives as potent influenza neuraminidase inhibitors: Design, synthesis, biological evaluation, ADME prediction and molecular docking studies.
Ye J; Yang X; Xu M; Chan PK; Ma C
Eur J Med Chem; 2019 Nov; 182():111635. PubMed ID: 31493744
[TBL] [Abstract][Full Text] [Related]
13. Design, Synthesis, and Biological Evaluation of Substituted 4,6-Dihydrospiro[[1,2,3]triazolo[4,5-
Xu J; Xie X; Ye N; Zou J; Chen H; White MA; Shi PY; Zhou J
J Med Chem; 2019 Sep; 62(17):7941-7960. PubMed ID: 31403780
[TBL] [Abstract][Full Text] [Related]
14. Influence of an additional amino group on the potency of aminoadamantanes against influenza virus A. II - Synthesis of spiropiperazines and in vitro activity against influenza A H3N2 virus.
Fytas C; Kolocouris A; Fytas G; Zoidis G; Valmas C; Basler CF
Bioorg Chem; 2010 Dec; 38(6):247-51. PubMed ID: 20926112
[TBL] [Abstract][Full Text] [Related]
15. Semisynthetic teicoplanin derivatives as new influenza virus binding inhibitors: synthesis and antiviral studies.
Bereczki I; Kicsák M; Dobray L; Borbás A; Batta G; Kéki S; Nikodém ÉN; Ostorházi E; Rozgonyi F; Vanderlinden E; Naesens L; Herczegh P
Bioorg Med Chem Lett; 2014 Aug; 24(15):3251-4. PubMed ID: 24974341
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of substituted flavones and aurones as potential anti-influenza agents.
Chintakrindi AS; Gohil DJ; Chowdhary AS; Kanyalkar MA
Bioorg Med Chem; 2020 Jan; 28(1):115191. PubMed ID: 31744778
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antiviral activities of adamantane spiro compounds. 1. Adamantane and analogous spiro-3'-pyrrolidines.
Lundahl K; Schut J; Schlatmann JL; Paerels GB; Peters A
J Med Chem; 1972 Feb; 15(2):129-32. PubMed ID: 4332673
[No Abstract] [Full Text] [Related]
18. Discovery and SAR study of piperidine-based derivatives as novel influenza virus inhibitors.
Wang G; Chen L; Xian T; Liang Y; Zhang X; Yang Z; Luo M
Org Biomol Chem; 2014 Oct; 12(40):8048-60. PubMed ID: 25184371
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antiviral activity of cyclopropyl-spirocarbocyclic adenosine, (4R,5S,6R,7R)-4-(6-amino-9H-purin-9-yl)-7-(hydroxymethyl)spiro[2.4]heptane-5,6-diol against hepatitis C virus.
Gadthula S; Rawal RK; Sharon A; Wu D; Korba B; Chu CK
Bioorg Med Chem Lett; 2011 Jul; 21(13):3982-5. PubMed ID: 21621997
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and Anti-Influenza Activity of Pyridine, Pyridazine, and Pyrimidine C-Nucleosides as Favipiravir (T-705) Analogues.
Wang G; Wan J; Hu Y; Wu X; Prhavc M; Dyatkina N; Rajwanshi VK; Smith DB; Jekle A; Kinkade A; Symons JA; Jin Z; Deval J; Zhang Q; Tam Y; Chanda S; Blatt L; Beigelman L
J Med Chem; 2016 May; 59(10):4611-24. PubMed ID: 27120583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
